This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Oncology

Delivery of systemic anticancer treatments: rapid guideline summary
Shorter radiotherapy treatment recommended for bowel cancer patients during pandemic
NICE publishes first rapid COVID-19 guidelines
Researchers discover prostate cancer ‘fingerprint’
Urine test could reduce unnecessary prostate cancer biopsies
Results of POUT trial in rare urinary cancer published
New technology for cancer diagnostics and drug testing
Worrying number of people delay going to the doctors in the UK
Revealing how mutations shape the tumour landscape in breast cancer
Major investment to transform leading cancer campus
Cancer vaccine could boost the effectiveness of immunotherapy
Research uncovers new path for melanoma detection and treatment
International survey reveals unacceptable cancer awareness divide
Momentum of support builds for early lung cancer screening in Scotland
Positive opinion for venetoclax + obinutuzumab in previously untreated CLL


Popular articles

Is vitamin D an important biomarker for symptom severity in COVID-19?
NICE publishes first rapid COVID-19 guidelines
How to assess systemic lupus erythematosus in clinical care
Acute use of NSAIDs for people with or at risk of COVID-19: rapid evidence summary
Sponsored: The benefits of working with the global leader in diagnostics to support the diagnosis of allergic and autoimmune diseases




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2020
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer